International (Amtrak train)

DMG Blockchain Solutions Announces Investment in Digital Asset Custody Solution

Retrieved on: 
Thursday, February 22, 2024

VANCOUVER, British Columbia, Feb. 22, 2024 (GLOBE NEWSWIRE) -- DMG Blockchain Solutions Inc. (TSX-V: DMGI) (OTCQB US: DMGGF) (FRANKFURT: 6AX) (“DMG”), a vertically integrated blockchain and data center technology company, announces it has committed CAD $3.5 million to establish a Calgary, Alberta based independent digital asset custody solution for institutional clients.

Key Points: 
  • VANCOUVER, British Columbia, Feb. 22, 2024 (GLOBE NEWSWIRE) -- DMG Blockchain Solutions Inc. (TSX-V: DMGI) (OTCQB US: DMGGF) (FRANKFURT: 6AX) (“DMG”), a vertically integrated blockchain and data center technology company, announces it has committed CAD $3.5 million to establish a Calgary, Alberta based independent digital asset custody solution for institutional clients.
  • The capital commitment for this digital asset custody solution will be made over time and as required to support the regulatory review process.
  • Sheldon Bennett, CFE, MBA - CEO and Director of DMG Blockchain Solutions and Chair of Systemic Trust.
  • Most recently as Binance Canada’s Chief Technology Officer, he spearheaded the implementation and launch of its Crypto Trading Platform and digital asset custody service.

R Systems International Limited Is Now Great Place To Work Certified

Retrieved on: 
Monday, February 12, 2024

R Systems International Limited, a leader in digital product engineering and technology solutions, announced its achievement of being certified as a Great Place To Work® in all ten countries where it has a full-time workforce.

Key Points: 
  • R Systems International Limited, a leader in digital product engineering and technology solutions, announced its achievement of being certified as a Great Place To Work® in all ten countries where it has a full-time workforce.
  • This notable recognition spans across India, USA, Canada, Singapore, Poland, Romania, Moldova, Malaysia, Indonesia, and Thailand, each country individually acknowledging R Systems as a preferred employer.
  • This certification is a testament to R Systems' dedication to creating an inclusive and dynamic work environment across its global operations.
  • Nitesh Bansal, CEO and Managing Director of R Systems International Limited, shared, "Achieving the Great Place to Work Certification™ across all ten countries where we operate reflects our vibrant culture and commitment to excellence.

Scheme Effective

Retrieved on: 
Monday, February 12, 2024

This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America.

Key Points: 
  • This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America.
  • This announcement is not an offer of securities for sale into the United States.
  • The Consideration Shares will be offered and sold for investment purposes only in the United States or to U.S.
  • RTW Bio reserves the right to refuse to accept any subscriptions, resales or other transfers of Consideration Shares to U.S.

Suspension of Trading in Shares

Retrieved on: 
Monday, February 12, 2024

The Consideration Shares will be offered and sold for investment purposes only in the United States or to U.S.

Key Points: 
  • The Consideration Shares will be offered and sold for investment purposes only in the United States or to U.S.
  • Consideration Shares will be offered and sold outside of the United States to investors that are not U.S.
  • The transferability of the Consideration Shares will be further restricted by the terms of the AI/QP Investor Letter, and any re-offer or resale of any Consideration Shares in the United States or to U.S.
  • RTW Bio reserves the right to refuse to accept any subscriptions, resales or other transfers of Consideration Shares to U.S.

Transaction Update

Retrieved on: 
Wednesday, February 7, 2024

This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America.

Key Points: 
  • This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America.
  • The Consideration Shares will be offered and sold for investment purposes only in the United States or to U.S.
  • Consideration Shares will be offered and sold outside of the United States to investors that are not U.S.
  • RTW Bio reserves the right to refuse to accept any subscriptions, resales or other transfers of Consideration Shares to U.S.

Update on the Scheme and Publication of Notice of Second General Meeting

Retrieved on: 
Tuesday, January 30, 2024

This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America.

Key Points: 
  • This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America.
  • The Consideration Shares will be offered and sold for investment purposes only in the United States or to U.S.
  • RTW Bio reserves the right to refuse to accept any subscriptions, resales or other transfers of Consideration Shares to U.S.
  • If the Second General Meeting is adjourned, the Voting Record Time for the adjourned meeting will be 6.30 p.m. on the date two calendar days before the date set for the adjourned meeting.

Results of First General Meeting

Retrieved on: 
Tuesday, January 30, 2024

This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America.

Key Points: 
  • This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America.
  • This announcement is not an offer of securities for sale into the United States.
  • The Consideration Shares will be offered and sold for investment purposes only in the United States or to U.S.
  • RTW Bio reserves the right to refuse to accept any subscriptions, resales or other transfers of Consideration Shares to U.S.

Update on the Scheme and Resignation of Directors

Retrieved on: 
Tuesday, January 30, 2024

This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America.

Key Points: 
  • This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America.
  • This announcement is not an offer of securities for sale into the United States.
  • The Consideration Shares will be offered and sold for investment purposes only in the United States or to U.S.
  • RTW Bio reserves the right to refuse to accept any subscriptions, resales or other transfers of Consideration Shares to U.S.

Publication of Circular and RTW Bio Prospectus

Retrieved on: 
Friday, January 5, 2024

Investors in RTW Bio will therefore not receive the protections afforded by the 1940 Act to investors in a registered investment company.

Key Points: 
  • Investors in RTW Bio will therefore not receive the protections afforded by the 1940 Act to investors in a registered investment company.
  • If RTW Bio is deemed to be an investment company and therefore is required to register under the 1940 Act, such requirement could prohibit RTW Bio from operating in its intended manner and could have a material adverse effect on RTW Bio.
  • RTW Bio reserves the right to refuse to accept any subscriptions, resales or other transfers of Consideration Shares to U.S.
  • RTW Bio further reserves the right to require the transfer or redemption of Consideration Shares held by any person for any reason, including circumstances that may prejudice the tax status of RTW Bio, may cause RTW Bio to be in violation of the Securities Act, the 1940 Act or any applicable state securities act or may cause RTW Bio to suffer any pecuniary, fiscal or administrative disadvantage which may be unlawful or detrimental to the interests or well-being of RTW Bio.

CMS(00867) Joins Hands with Pharmaron to Promote the Singapore Manufacturing Plant Acquisition and CDMO Business in SEA

Retrieved on: 
Tuesday, January 2, 2024

Ltd. ( defined as “Singapore manufacturing plant ”).

Key Points: 
  • Ltd. ( defined as “Singapore manufacturing plant ”).
  • The Singapore manufacturing plant has advanced manufacturing machines, equipment and first-class infrastructure.
  • It will serve as the plant and site for PharmaGend to carry out pharmaceutical formulation, finishing, and packaging business, accelerating the formulation Contract Development and Manufacturing Organization (formulation CDMO) business development in Singapore.
  • The smooth progress of the formulation CDMO cooperation is of great significance to CMS in accelerating its business development in Southeast Asia.